155 related articles for article (PubMed ID: 9972671)
1. Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia.
Touraine P; Deneux C; Plu-Bureau G; Mauvais-Jarvis P; Kuttenn F
J Endocrinol Invest; 1998 Dec; 21(11):732-6. PubMed ID: 9972671
[TBL] [Abstract][Full Text] [Related]
2. The safety of physiological estrogen plus progestin replacement therapy and with oral contraceptive therapy in women with pathological hyperprolactinemia.
Corenblum B; Donovan L
Fertil Steril; 1993 Mar; 59(3):671-3. PubMed ID: 8458475
[TBL] [Abstract][Full Text] [Related]
3. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
4. Hyperprolactinemia with prolonged amenorrhea reversed with bromocriptine in a menopausal woman.
Goldman M; Steinberger A; Ganti S
Am J Obstet Gynecol; 1988 Jan; 158(1):117-8. PubMed ID: 3122579
[TBL] [Abstract][Full Text] [Related]
5. The role of prolactin in the menopause.
Metka M; Holzer G; Raimann H; Heytmanek G; Hartmann B; Kurz C
Maturitas; 1994 Dec; 20(2-3):151-4. PubMed ID: 7715467
[TBL] [Abstract][Full Text] [Related]
6. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of 246 hyperprolactinemic patients.
Touraine P; Plu-Bureau G; Beji C; Mauvais-Jarvis P; Kuttenn F
Acta Obstet Gynecol Scand; 2001 Feb; 80(2):162-8. PubMed ID: 11167213
[TBL] [Abstract][Full Text] [Related]
8. [Effects of therapy and pregnancy on hyperprolactemia caused by a pituitary adenoma. A clinical case].
Pasinetti E; Schivardi MR; Falsetti L; Gastaldi A
Minerva Ginecol; 1989 Mar; 41(3):157-60. PubMed ID: 2666885
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinemia: comparison of thyrotropic-releasing hormone and tomography.
Shangold GA; Kletzky OA; Marrs RP; Mishell DR
Obstet Gynecol; 1984 Jun; 63(6):771-5. PubMed ID: 6427715
[TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia in postmenopausal women.
Maor Y; Berezin M
Fertil Steril; 1997 Apr; 67(4):693-6. PubMed ID: 9093196
[TBL] [Abstract][Full Text] [Related]
12. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy.
Klaiber EL; Broverman DM; Vogel W; Peterson LG; Snyder MB
Psychoneuroendocrinology; 1997 Oct; 22(7):549-58. PubMed ID: 9373888
[TBL] [Abstract][Full Text] [Related]
13. Changes in the prolactin serum isoforms secreted by a pituitary adenoma associated with therapy.
Morán C; Tena G; Fonseca ME; Ochoa R; Bermúdez JA; Zárate A
Arch Med Res; 1994; 25(1):1-3. PubMed ID: 8019107
[TBL] [Abstract][Full Text] [Related]
14. Pathological hyperprolactinemia suppresses hot flashes in menopausal women.
Scoccia B; Schneider AB; Marut EL; Scommegna A
J Clin Endocrinol Metab; 1988 Apr; 66(4):868-71. PubMed ID: 3346363
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of therapeutic outcomes of polycystic ovary syndrome patients with hyperprolactinemia].
Shi YH; Sheng Y; Chen ZJ; Yan JH; Gao Q; Liu H; Ma ZX
Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):251-3. PubMed ID: 18843962
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactive prolactin in breast milk and plasma of women with hyperprolactinemia, galactorrhea and menstrual dysfunction.
Yuen BH
Int J Fertil; 1986; 31(1):67-70. PubMed ID: 2908279
[TBL] [Abstract][Full Text] [Related]
17. Alternative Treatment Strategies in Women Poorly Tolerating Moderate Doses of Bromocriptine.
Krysiak R; Szkróbka W; Okopień B
Exp Clin Endocrinol Diabetes; 2017 Jun; 125(6):360-364. PubMed ID: 28073129
[No Abstract] [Full Text] [Related]
18. Increased thyroid-stimulating hormone response to thyrotropin-releasing hormone in hyperprolactinemic women.
Seki K; Kato K
J Clin Endocrinol Metab; 1985 Dec; 61(6):1138-41. PubMed ID: 3932450
[TBL] [Abstract][Full Text] [Related]
19. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
[TBL] [Abstract][Full Text] [Related]
20. Effects of pregnancy, delivery and lactation in hyperprolactinemia with prolactin producing pituitary adenoma.
Kondo I; Suganuma N; Kimura T; Matsuzawa K; Osawa M; Masahashi T; Mizutani S; Narita O; Tomoda Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):595-600. PubMed ID: 2754290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
